BBP

$82.23

Fund Essentials - as of Oct 31, 2025

Net Assets
$32M
Expense Ratio
0.79%
Dividend Yield (Current)
-
Holdings
58
Inception Date
Dec 16, 2014
Fund Family
Virtus Investment Partners
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+0.02%
1 Year+0.33%
3 Year+0.56%
5 Year+0.40%
10 Year+2.54%

Asset Allocation

Stocks: 100.08%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
TVTXTravere Therapeutics Inc3.49%
IONSIonis Pharmaceuticals Inc2.91%
INSMInsmed Inc2.87%
AUPH:CAAurinia Pharmaceuticals Inc2.70%
ROIVRoivant Sciences Ltd2.65%
Top 10 Concentration: 27.11%Report Date: Oct 31, 2025

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$0.07
Dec 20, 2017

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
+2.44%
YTD
+32.83%
1 Year
+32.83%
3 Year
+55.65%

Top 10 Holdings (27.1% of portfolio)

#TickerNameSectorWeight
1TVTXTravere Therapeutics IncHealth Care3.49%
2IONSIonis Pharmaceuticals IncHealth Care2.91%
3INSMInsmed IncHealth Care2.87%
4AUPH:CAAurinia Pharmaceuticals IncHealth Care2.70%
5ROIVRoivant Sciences LtdHealth Care2.65%
6TARSTarsus Pharmaceuticals IncHealth Care2.61%
7LGNDLigand Pharmaceuticals IncHealth Care2.57%
8MDGLMadrigal Pharmaceuticals IncHealth Care2.54%
9TBPHTheravance Biopharma IncHealth Care2.39%
10BBIOBridgebio Pharma IncHealth Care2.38%